2 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Unknown 2 |
Follow Fen Li: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multi-omics Studies on the Efficacy of Telitacicept in Chinese SLE Patients Telitacicept, Hydroxychloroquine, Prednisone - Systemic Lupus Erythematosus | Phase 4 | Unknown | Fen Li | 30 | 2022-12-31 | 2024-01-17 |
| Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World" methotrexate(necessary), infliximab, etanercept - Rheumatoid Arthritis | Phase 4 | Unknown | Fen Li | 240 | 2016-01-01 | 2016-08-25 |
Arthritis, Rheumatoid (1) · Lupus Erythematosus, Systemic (1)
Prednisone (2) · Adalimumab (1) · Anti-Inflammatory Agents, Non-Steroidal (1) · Cyclophosphamide (1) · Etanercept (1) · Glucocorticoids (1) · Hydroxychloroquine (1) · Infliximab (1) · Leflunomide (1) · Licensure (1) · Methylprednisolone (1) · Mycophenolic Acid (1) · Tacrolimus (1) · prednylidene (1) · telitacicept (1)
China (1)